{
    "clinical_study": {
        "@rank": "25094", 
        "arm_group": [
            {
                "arm_group_label": "Control groups with only analgesics", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Control groups will receive only analgesics."
            }, 
            {
                "arm_group_label": "Naftopidil", 
                "arm_group_type": "Active Comparator", 
                "description": "This interventional group will receive analgesics and naftopidil 75mg po qd."
            }
        ], 
        "brief_summary": {
            "textblock": "This study is to investigate whether naftopidil is effective or not for the spontaneous\n      passage of ureteral stones with sizes of 3 to 10 mm."
        }, 
        "brief_title": "Medical Expulsive Therapy for Ureter Stone Using Naftopidil", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Ureter Stones", 
        "condition_browse": {
            "mesh_term": [
                "Calculi", 
                "Ureteral Calculi", 
                "Ureterolithiasis"
            ]
        }, 
        "detailed_description": {
            "textblock": "1. Enrollment\n\n             1. patients with ureteral stones of sizes from 3 to 10 mm\n\n             2. patients aged more than 18 years\n\n        2. Randomization\n\n             1. naftopidil 75 mg qd for 14 days or placebo\n\n             2. Standard treatment with pain-killers were also applied.(aceclofenac)\n\n        3. Follow-up for 28 days\n\n             1. We confirm the stone free status by CT or X-ray films at 14th and 28th days.\n\n             2. Rates of active treatment will be also evaluated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  >= 20 years\n\n          -  single 3 to 10 mm ureter stone (longest diameter)\n\n        Exclusion Criteria:\n\n          -  Presence of multiple ureter stones\n\n          -  Renal insufficiency (serum Cr > 1.4 mg/dL)\n\n          -  Febrile urinary tract infections(fever > 38\u00b0C, evidence of urinary infection)\n\n          -  pregnancy or breast feeding\n\n          -  solitary kidney\n\n          -  hypersensitivity to naftopidil\n\n          -  current use of any alpha-blocker, calcium-channel blocker, corticosteroid (within 4\n             weeks)\n\n          -  moderate or severe cardiovascular or cerebrovascular disease\n\n          -  hepatic dysfunction (>2 x normal upper limit)\n\n          -  significant active medical illness which in the opinion of the investigator would\n             preclude protocol treatment\n\n          -  Genetic disorder such as Galactose intolerance, Lapp Lactase deficiency,\n             Glucose-Galactose malabsorption"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01952314", 
            "org_study_id": "SNUBH-URO-2012-03", 
            "secondary_id": "SNUBH-URO-2012-03-MET"
        }, 
        "intervention": {
            "arm_group_label": "Naftopidil", 
            "description": "naftopidil 75mg po qd for 28 days with standard analgesic treatment", 
            "intervention_name": "Naftopidil 75mg po qd", 
            "intervention_type": "Drug", 
            "other_name": "Flivas(TM) in South Korea"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Analgesics", 
                "Naftopidil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 24, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Minchul Cho, M.D., Ph.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Goyang", 
                        "country": "Korea, Republic of", 
                        "state": "Kyunggi"
                    }, 
                    "name": "Donguk University Ilsan Hospital"
                }, 
                "investigator": {
                    "last_name": "Minchul Cho, M.D., Ph.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sangchul Lee, M.D., Ph.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Seongnam", 
                        "country": "Korea, Republic of", 
                        "state": "Kyunggi", 
                        "zip": "463-712"
                    }, 
                    "name": "Seoul National University Bundang Hospital"
                }, 
                "investigator": {
                    "last_name": "Sangchul Lee, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jong Jin Oh, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Seongnam", 
                        "country": "Korea, Republic of", 
                        "state": "Kyunggi", 
                        "zip": "463-712"
                    }, 
                    "name": "CHA Bundang Medical Center, Bundang hospital"
                }, 
                "investigator": {
                    "last_name": "Jong Jin Oh, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sang Wook Lee, M.D., Ph.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Chuncheon", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Kangwon National University Hospital"
                }, 
                "investigator": {
                    "last_name": "Sang Wook Lee, M.D., Ph.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Woong Na, M.D., Ph.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "National Medical Center"
                }, 
                "investigator": {
                    "last_name": "Woong Na, M.D., Ph.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "kmoretry@daum.net", 
                    "last_name": "Sung Yong Cho, M.D., Ph.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Seoul National University Boramae Medical Center"
                }, 
                "investigator": {
                    "last_name": "Sung Yong Cho, M.D., Ph.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Medical Expulsive Therapy for Ureter Stone Using Naftopidil: Multicenter, Randomized, Double-blind, Placebo Controlled Study", 
        "overall_contact": {
            "email": "drboss@korea.com", 
            "last_name": "Chang Wook Jeong, M.D., Ph.D.", 
            "phone": "82-10-8933-4353"
        }, 
        "overall_contact_backup": {
            "email": "kmoretry@daum.net", 
            "last_name": "Sung Yong Cho, M.D., Ph.D.", 
            "phone": "82-10-6287-0217"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Chang Wook Jeong, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Rate of stone-free as confirmed by non-contrast CT, intravenous urography or simple x-ray (only for radio-opaque stone)", 
            "measure": "Stone-free rate at 14th day of study", 
            "safety_issue": "No", 
            "time_frame": "14th day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01952314"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Chang Wook Jeong", 
            "investigator_title": "M.D, Ph.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Stone-free rate at 28th day of study", 
                "safety_issue": "No", 
                "time_frame": "28th day"
            }, 
            {
                "measure": "Duration to stone passage within 28days of study", 
                "safety_issue": "No", 
                "time_frame": "for 28 days"
            }, 
            {
                "measure": "amount of analgesics used for 28 days of study", 
                "safety_issue": "No", 
                "time_frame": "for 28 days"
            }, 
            {
                "description": "Active treatments include shock-wave lithotripsy, ureteroscopic ureterolithotomy, ureteral stenting or other surgical treatment", 
                "measure": "Rate of active treatment", 
                "safety_issue": "No", 
                "time_frame": "for 28 days"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Dong-A Pharmaceutical Co., Ltd.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}